6.
Jesus D, Larosa M, Henriques C, Matos A, Zen M, Tome P
. Systemic Lupus Erythematosus Disease Activity Score (SLE-DAS) enables accurate and user-friendly definitions of clinical remission and categories of disease activity. Ann Rheum Dis. 2021; 80(12):1568-1574.
DOI: 10.1136/annrheumdis-2021-220363.
View
7.
La Rosee P, Horne A, Hines M, von Bahr Greenwood T, Machowicz R, Berliner N
. Recommendations for the management of hemophagocytic lymphohistiocytosis in adults. Blood. 2019; 133(23):2465-2477.
DOI: 10.1182/blood.2018894618.
View
8.
Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R
. 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Ann Rheum Dis. 2019; 78(9):1151-1159.
DOI: 10.1136/annrheumdis-2018-214819.
View
9.
Furin J, Cox H, Pai M
. Tuberculosis. Lancet. 2019; 393(10181):1642-1656.
DOI: 10.1016/S0140-6736(19)30308-3.
View
10.
Benz K, Amann K
. Thrombotic microangiopathy: new insights. Curr Opin Nephrol Hypertens. 2010; 19(3):242-7.
DOI: 10.1097/MNH.0b013e3283378f25.
View
11.
Aziz A, Castaneda E, Ahmad N, Veerapalli H, Rockferry A, Lankala C
. Exploring Macrophage Activation Syndrome Secondary to Systemic Lupus Erythematosus in Adults: A Systematic Review of the Literature. Cureus. 2021; 13(10):e18822.
PMC: 8592789.
DOI: 10.7759/cureus.18822.
View
12.
Magil A, McFadden D, Rae A
. Lupus glomerulonephritis with thrombotic microangiopathy. Hum Pathol. 1986; 17(2):192-4.
DOI: 10.1016/s0046-8177(86)80293-3.
View
13.
Patel A, Desai P, Banskota S, Edigin E, Manadan A
. Hemophagocytic Lymphohistiocytosis Hospitalizations in Adults and Its Association With Rheumatologic Diseases: Data From Nationwide Inpatient Sample. J Clin Rheumatol. 2020; 28(1):e171-e174.
DOI: 10.1097/RHU.0000000000001670.
View
14.
Hannah J, DCruz D
. Pulmonary Complications of Systemic Lupus Erythematosus. Semin Respir Crit Care Med. 2019; 40(2):227-234.
DOI: 10.1055/s-0039-1685537.
View
15.
Pattanashetti N, Anakutti H, Ramachandran R, Rathi M, Sharma A, Nada R
. Effect of Thrombotic Microangiopathy on Clinical Outcomes in Indian Patients With Lupus Nephritis. Kidney Int Rep. 2017; 2(5):844-849.
PMC: 5733673.
DOI: 10.1016/j.ekir.2017.04.008.
View
16.
Kello N, El Khoury L, Marder G, Furie R, Zapantis E, Horowitz D
. Secondary thrombotic microangiopathy in systemic lupus erythematosus and antiphospholipid syndrome, the role of complement and use of eculizumab: Case series and review of literature. Semin Arthritis Rheum. 2019; 49(1):74-83.
DOI: 10.1016/j.semarthrit.2018.11.005.
View
17.
DallAra F, Cavazzana I, Frassi M, Taraborelli M, Fredi M, Franceschini F
. Macrophage activation syndrome in adult systemic lupus erythematosus: report of seven adult cases from a single Italian rheumatology center. Reumatismo. 2018; 70(2):100-105.
DOI: 10.4081/reumatismo.2018.1023.
View
18.
Gupta D, Mohanty S, Thakral D, Bagga A, Wig N, Mitra D
. Unusual Association of Hemophagocytic Lymphohistiocytosis in Systemic Lupus Erythematosus: Cases Reported at Tertiary Care Center. Am J Case Rep. 2016; 17:739-744.
PMC: 5065291.
DOI: 10.12659/ajcr.899433.
View
19.
Cuchacovich R, Gedalia A
. Pathophysiology and clinical spectrum of infections in systemic lupus erythematosus. Rheum Dis Clin North Am. 2009; 35(1):75-93.
DOI: 10.1016/j.rdc.2009.03.003.
View
20.
Weitzman S
. Approach to hemophagocytic syndromes. Hematology Am Soc Hematol Educ Program. 2011; 2011:178-83.
DOI: 10.1182/asheducation-2011.1.178.
View